Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination.

Pedersen, Rune M; Bang, Line L; Madsen, Lone W; Sydenham, Thomas V; Johansen, Isik S; Jensen, Thøger G; Justesen, Ulrik S; Andersen, Thomas E

Pedersen, Rune M; Bang, Line L; Madsen, Lone W; Sydenham, Thomas V; Johansen, Isik S; Jensen, Thøger G; Justesen, Ulrik S; Andersen, Thomas E.

Emerg Infect Dis ; 28(6): 1274-1275, 2022 06.

Article em En | MEDLINE | ID: mdl-35356875

RESUMO

The SARS-CoV-2 Omicron variant BA.2 sublineage is rapidly replacing earlier Omicron lineages, suggesting BA.2 has increased vaccine evasion properties. We measured neutralization titers of authentic BA.1 and BA.2 isolates in serum samples from persons who received the BNT162b2 booster vaccine. All samples neutralized BA.1 and BA.2 at equal median values.

Assuntos

COVID-19; SARS-CoV-2; Vacina BNT162; COVID-19/prevenção & controle; Vacinas contra COVID-19; Humanos; Vacinação

Palavras-chave

BA.1; BA.2; COVID-19; Denmark; Omicron; SARS; SARS-CoV-2; coronavirus; coronavirus disease; respiratory infections; serum neutralization; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article